Mossman Farming, a dairy farm on the west Welsh coast which has been stricken by bovine TB, has become the first to gain permission to trial PBD Biotech’s rapid Actiphage blood test for Mycobacterium bovis (M. bovis). 

PBD Biotech says the Actiphage test offers the potential to revolutionise control of bovine TB by allowing detection of the disease within hours from a blood or milk sample.

Last November, the Welsh Government announced a new policy that allowed the use of non-validated tests such as Actiphage in herds affected by a TB breakdown. It followed a similar protocol to one authorised by the UK Government last year for cattle herds in England after the test was used as part of a successful private eradication plan on a Devon dairy farm.

Mossman Farming, in Ceredigion, is located in an area of chronic breakdown. It is a spring-calving milking herd with a total stock of 529, to date 312 dairy cows have been slaughtered. Farmer Chris Mossman agreed to trial Actiphage after hearing about the Gatcombe pilot.

Chris said: "TB is a massive problem in Ceredigion, so when I heard about Actiphage’s use at Gatacombe, helping to clear that dairy herd for the first time in six years, I wanted to try and replicate those findings here. Me – and many other farmers – are losing large numbers of animals. I’m trying to do all I can to get rid of this disease from my herd."

In Spring 2019, The Office of the Chief Veterinary Officer for Wales granted permission for Robert Price-Jones MRCVS to use Actiphage to screen high-risk cattle for M. bovis.

Robert, who has been leading the trial, said: "Actiphage is able to identify the presence of relatively low numbers of M. bovis in the blood stream of infected cattle. It is not dependent upon an immune system response to the pathogen - in contrast to current validated tests - and so has greater sensitivity than such as the official Tuberculin SICCT skin test.

"The benefit of using Actiphage is that it offers the potential for eradicating the disease from the farm; as early identification of animals at risk of bovine TB enables heightened disease management and control."

Under the terms of the Welsh Government’s protocol, cattle not condemned for slaughter can be tested with Actiphage. Those that give a positive result are identified with a ‘management’ marker, monitored and milked separately.

To prevent further contamination of the environment and to minimise risk to uninfected cattle, animals found to be ‘shedders’ are removed from the farm.

Although a decision to remove cattle based on a non-validated test will be at the farmers’ own expense, the APHA (Animal and Plant Health Agency) has confirmed that during the trial, where a positive result is confirmed with statutory tests, the animals will be removed with compensation as normal.

So far, 100 animals from Mossman Farming have been tested with Actiphage and Robert Price-Jones is preparing a paper to publish the findings in early 2020.

PBD Biotech is now seeking more farms to trial Actiphage in order to gain the World Organisation for Animal Health (OIE) validation. The company is offering reduced cost testing to support trials where the findings are made available to support validation of the test.

North Star Vets, which launched last year with a business model that gives head vets at each practice a stake in the business, has opened two new sites in Sandymoor and Warrington.

Sandymoor Vets and Westbrook Vets are headed by Clinic directors, Dr Becky Crossfield and Dr Rhys Peters, supported by a team of 18 vets, nurses and receptionists at each practice and a six-strong head office support team providing finance, marketing, property and HR expertise.

North Star Vets which was launched by Dr Sean Cleary, Dr Richard Thomas and chartered accountant, Jane Platt, opened its first practice about 11 months ago. 

The company is aiming to grow to 10 practices over the next four years.

Sea, said: “The ethos of North Star Vets is about giving the next generation of ambitious vets an opportunity to own a share of their own practice and to run it the way they want, without the risk and substantial capital investment that would usually be required to open their own site.

“Our practices also have the added benefit of our central resources spanning clinical, financial, HR, marketing, procurement and property expertise, which are all required to create a successful business.

"In addition, clients enjoy the service levels and continuity that owner managed businesses are renowned for.”

“We knew our offering would be attractive to high quality vets who have the ambition and drive to go beyond heading up a corporate practice, and want to take their career, experience and earning potential to the next level.

“Burford Lane Vets has been very successful achieving a monthly turnover of £100,000 within its first 12 months and we’re very pleased to follow this with the opening of Westbrook Vets and Sandymoor Vets.

"Both practices are in great locations and have undergone high quality fit outs that incorporate all the latest equipment and facilities.

"When this is combined with the knowledge, experience and enthusiasm of Becky and Rhys, it’s easy to see why both practices are proving popular, with almost 700 clients already registered at Westbrook Vets and more than 400 at Sandymoor Vets.

“We’re already planning to open two more sites in the North West, and are currently looking for high-calibre vets who want to be masters of their own destiny by becoming part of our unique co-ownership model.

"Anyone interested should contact us now.”

www.northstarvets.co.uk

Ceva Animal Health has launched a new TV advertising campaign designed to raise awareness of problems owners may face in a multi-cat environment.

The Cat Cabin Fever campaign will run for four weeks.

Ceva says the 20 second TV ads have been designed to strike a chord with viewers who have more than one cat in their household, where 'sometimes sharing just isn't an option'. Highlighted in particular is the Feliway Diffuser which releases natural pheromones into a room to help cats feel at ease, allowing them to cope with stressful situations and prevent unwanted behaviour.  

Malcolm Laurie, head of marketing at Ceva, said: "We know that there are more than 8million cats in the UK and only 2.5million cat households, therefore the majority of households must have more than one cat.

"However, cats are solitary animals, which makes living with other cats difficult at times. This campaign is focused on making the lives of cat owners and their pets as harmonious as possible, including lots of top tips on how to ease any tensions in such an environment."

Ceva has also produced a multi-cat leaflet designed to give owners specific advice on how to provide the correct environment for our feline friends

The advertising campaign will be supported by online competitions, marketing materials for veterinary clinics and retailers, which include a checklist for a cat friendly home, and PR.

For more information, visit: http://www.feliway.co.uk/.

Purina has donated £100,000 to Medical Detection Dogs (MDD), to support the charity's training and potential deployment of COVID-19 sniffer dogs in public spaces.

The company is also working with the UK charity to call for the creation of international standards in the training and deployment of sniffer dogs.

Earlier this week, Medical Detection Dogs announced the findings of its research on scenting COVID-19, confirming that dogs can play a major role in public safety through their ability to detect the virus’ odour.

Researchers will now move to trial the dogs at sites such as ports of entry and public spaces, where dogs can screen individuals rather than samples and contribute to the fight against the virus by detecting COVID-19 carriers.

Sniffer dog schemes are currently being piloted in countries including Finland, Russia, Italy and France, but there is currently no centralised best practice process for such programmes.

Medical Detection Dogs and Purina are calling for:

• Time limits on deployment, to ensure that a COVID-19 detection dog will only be operationally deployed for approximately four hours over the course of an eight-hour working day. Each dog will also ideally be limited to 20-minute shifts to prevent fatigue and ensure reliable performance
• Common standards on housing for dogs to ensure dogs are not stressed or distracted by close interaction with people
• Agreed guidance for the training and deployment of future schemes around the world

Medical Detection Dogs founder and CEO Dr Claire Guest said: “Sniffer dogs have the potential to make an important contribution to the fight against COVID-19 and future pandemics. Researchers around the world are urgently working to meet that need, but it is vital that we collaborate, share the knowledge we have gained on the incredible abilities of our dogs and formalise best practice in training and deployment.

"Along with Purina we want to call for international collaboration between organisations around the world on the implementation of disease detection and research. Our vision is to guarantee that dogs are well-treated and consistent in their performance, and support the reliable, safe creation of similar schemes in developing countries, where dogs could play a huge role in halting the spread of this disease and future pandemics.”

Jeff Hamilton, CEO at Nestlé Purina PetCare EMENA, said: “Purina and Medical Detection Dogs share a belief in the positive role and impact of dogs in society.  These dogs could provide fast, effective and non-invasive diagnosis and help to create safer spaces for us all, but we should ensure that each of them is trained safely, humanely and able to effectively perform their important role in detecting COVID-19."

The BVDA has teamed up with IM3 to launch a new course to help veterinary surgeons improve their knowledge and practical skills in dentistry.

The 2-day course, which includes both theory and practical sessions, will be taught by Ingrid Tundo, lecturer and head of the Dentistry and Oral Surgery Department at the University of Edinburgh (pictured right), at IM3's Advanced Centre for Education near Dublin on the 10th and 11th August 2021.

The course will cover all the basic aspects of veterinary dentistry including oral examination and charting, dental radiography, local anaesthetic techniques and basic oral surgery including extractions.

The cost of the course is £600 and there's a 15% discount for BVDA members (so if you're interested in the course, then joining the BVDA is a bit of a no-brainer). 

To register, visit: https://www.bvda.co.uk/education/courses/essential-dentistry-for-vets, or email Rob Davis (BVDA Education Officer) at davis4ginger@yahoo.co.uk for further information.

Rabbit Awareness Week (RAW), which starts on 23rd May this year, is calling on veterinary practices to sign up to its free health check scheme to help raise awareness of rabbits' behavioural needs.

Participating practices will receive free support packs to help them advertise and run their health check events, as well as goodie bags to give out to clients who bring their rabbits in.

The 2011 event will see a PR, advertising and marketing campaign with backing from Burgess Excel and RAW partners, including Panacur Rabbit, Petplan Insurance, RSPCA, PSDA, The Blue Cross, Wood Green Animal Shelters and RWAF (Rabbit Welfare Association & Fund), which are the driving forces behind the RAW 2011 initiative.

Naomi Chatterley, marketing manager at Burgess Excel, said: "Following the success of last year's event, our aim is to create an even bigger success in 2011. This May, the focus is on raising awareness of rabbits' emotional welfare needs by encouraging owners to consider their rabbit's mental and emotional health. Rabbits that are not stimulated both mentally and physically tend to develop behavioral problems such as fur plucking, depression or severe aggression. Our sole aim is to educate owners about responsible rabbit ownership and improve the wellbeing of Britain's 3^rd most popular pet."

If you are interested in supporting RAW 2011 by hosting rabbit healthcare clinics at your surgery, please visit http://www.rabbitawarenessweek.co.uk/  to order your free support kit and register your event.

Dechra Veterinary Products has reduced the price of two key products in its Veterinary Essentials range to help practices respond to the challenging economic climate.

Atipam 5 ml is now the same price per ml as Atipam 10ml. Used for the reversal of the sedative effects of medetomidine and dexmedetomidine in cats and dogs, practices can now choose the size that suits them best. Additionally, during January, for every 15ml purchased an extra 5ml will be provided to practices free of charge.

Thyroxyl, used for the treatment of hypothyroidism in dogs, has also been reduced in price by 15 per cent. Practices that include Thryoxyl as part of the newly introduced Essential Purchase Plan can also make further savings. 

To find out more about the Veterinary Essentials range, including further costs savings with an Essentials Purchase Plan and free margin development advice, call Liz Rawlings on 01743 441632.

On the 15th anniversary of the foot and mouth disease (FMD) outbreak, the BVA has emphasised the vital role of vets and veterinary surveillance in protecting the UK from devastating disease outbreaks.

The outbreak (confirmed in an abattoir on 19 February 2001) involved the slaughter of more than six million animals causing dire emotional and financial impacts on farmers, vets and rural businesses. Vets from across the profession, including those not working with livestock, were called upon to assist with disease control.

BVA is marking the anniversary by asking the government to reflect on the vital role of vets and veterinary surveillance after Defra was asked to make a further 15% budget cut in last year’s Autumn Statement (November 2015). 

BVA President Sean Wensley said: "15 years on from the devastation of the 2001 outbreak the UK must remain vigilant for Foot and Mouth Disease, but important lessons learned mean we are now better prepared if another outbreak does occur. Today we would have an immediate standstill on livestock movements, improved traceability systems and the possibility of using vaccination as part of the overall control strategy. But we cannot be complacent and the anniversary is an opportunity to reflect on the vital role of vets and veterinary surveillance in protecting the UK from disease.

"In recent years we have seen the impact of significant cuts to Defra's budget on veterinary fees for TB testing and other OV services. Vets’ frontline roles must be recognised and supported, backed up by an effective, coordinated system of data capture that will enable us to make the necessary links to detect and control new disease threats. We can never be free from the risk of disease, and in recent years the emergence of Schmallenberg and re-emergence of Bluetongue have brought new challenges. It is essential that we have the coordination and capability to identify and diagnose in order to protect our national herd and flock."

The BVA has issued a statement in response to new research data published last week by Niels Pedersen from the Centre of Companion Animal Health, University of California, into breed health of the English bulldog¹. 

Sean Wensley, President of the British Veterinary Association, said: "The research released today reflects the seriousness of the health problems associated with English bulldogs that our members are seeing in practice. Revision of breed standards, to include evidence-based limits on physical features such as muzzle shortness, and full consideration of other approaches such as outcrossing, are now needed to ensure high risk breeds, such as the English bulldog, do not continue to suffer unnecessarily.

"Vets are reporting concerning trends in dog health and welfare linked to the rise in ownership of brachycephalic breeds, such as bulldogs, and we are unequivocal in the need for all those with roles to play – including vets, breeders, breed societies, the pet-buying public as well as others – to take action to combat the health problems that brachycephalic breeds experience due to extreme conformation. These issues include severe lifelong breathing difficulties, corneal ulcers, skin disease, a screw-shaped tail which is linked to painful spine abnormalities, and the inability to give birth naturally.

"As part of their pre-purchase research, prospective dog owners should consider the health harms perpetuated in dogs by purchasing brachycephalic breeds and choose a healthier alternative breed, or crossbreed, instead, and local veterinary practices are ideally placed to give this advice. Brachycephalic dogs should not be seen as cute or desirable, rather as dogs predisposed to a lifetime of poor health, and English bulldogs should not be hailed as a national symbol for the UK where animal welfare is strongly valued.

"Vets have a duty to always prioritise the best interests of their pet patients, which, for affected animals, can involve performing surgical procedures to correct conformational disorders. They have a concurrent duty to be part of initiatives that aim to address the health and welfare of a breed beyond the individual affected animal.

"This is why BVA promotes the importance of vets submitting data on caesarean sections and conformation-altering surgery to the Kennel Club, to improve the future of dog health and welfare."

1. A genetic assessment of the English bulldog, Niels C. Pedersen, Ashley S. Pooch and Hongwei Liu, Canine Genetics and Epidemiology 2016 3:6

The RCVS Disciplinary Committee has agreed to accept undertakings from Cardiff-based veterinary surgeon Adrian John Westwood that he requests the removal his name from the Register of Veterinary Surgeons and agree never to apply to be restored to it.

Dr Westwood, who now lives in Australia, had been referred to the Committee in relation to a number of charges against him relating to the treatment of a cat at his former practice in Cardiff in October 2015.

He was not present at the inquiry and had requested that his solicitor, Tony Wilson, act on his behalf.

Mr Wilson made an application to the Committee that the hearing should be adjourned contingent on a form of undertakings being accepted. These undertakings were that Dr Westwood’s name be removed from the Register with immediate effect and that he never apply to be restored to the Register under any category.

The application was granted by the Committee, taking into account a number of factors. These included the fact that Dr Westwood has retired as a veterinary surgeon, that he has closed his practice and returned to his home in Australia with no intention of returning to the UK, and that animal welfare and the reputation of the profession have been protected as Dr Westwood will no longer be in practice.

The Committee noted that there were several precedents for concluding cases in such a manner, and that the application was not objected to by the complainant or opposed by the College.

Dr Westwood’s name was removed from the Register of Veterinary Surgeons with immediate effect as of Monday 14 August 2017.

Norbrook has launched Loxicom 0.5mg/ml oral suspension for small dogs, indicated for the alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders.

Loxicom Oral Suspension comes in a clear 15ml bottle which allows vets and clients to monitor levels of the product and re-order when necessary.

Loxicom 0.5mg/ml for Dogs comes with two sizes of syringe, a 1ml syringe graduated from 0.25kg-5kg to treat even the smallest of dog breeds accurately, and a 5ml syringe graduated from 1kg-25kg to treat small and medium dog breeds. The syringes plug securely into the bottle to ensure a tight-fitting connection and minimal leakage when administering the product.

This new oral suspension joins the range of 1.5mg/ml oral suspensions for Dogs and 5mg/ml injections for Dogs and Cats, launched in 2009, and the 0.5mg/ml oral suspension for Cats launched earlier this year at the BSAVA Congress.

Research carried out by YouGov on behalf of the Dogs Trust, has shown that as the cost of living crisis develops, 68% of dog owners in the UK feel worried, to some extent, about how they will care for their dog in the next year, with 30% either ‘very’ or ‘fairly’ worried.

35% think the rising cost of living is already making it more difficult to give their dogs all they need.

By far the greatest worry was how they would manage to pay vet bills, which 49% named as their main concern.

The second biggest worry was affording dog food (17%), closely followed by insurance (15%).

Non-dog owners in the UK, meanwhile, were asked whether the rising cost of living would prevent them from adopting or buying a dog. Over half (54%) said that it would.

The Dogs Trust says this research mirrors its own experience, seeing a steady increase in the number of requests from owners who have decided to give up their dog.

It harks back to the year after the 2008 recession, when the increase in the number of stray and abandoned dogs reached over 25% in the UK.

Owen Sharp, Dogs Trust CEO, said: "We know from the experience of the 2008 recession that economic crisis can and will lead to people needing to give up their beloved dogs. Sadly, many loving dog owners simply won’t be able to afford to keep them.

“At Dogs Trust we’re rehoming and fostering dogs as quickly as we can - but as soon as we free up a kennel space, there’s a dog to fill it again.

“We’ve already taken 13,000 calls this year from owners who need to give up their dogs – a 58% increase on last year.

“We know that dog owners need immediate help and we’re working hard to find ways to support them - but it takes time.

“However, there are other ways we help, like our Hope Project, which aims to keep anyone experiencing a housing crisis and their dog together, and helping people find other services such as pet food banks or local charities that could ease the burden.”  

“We want dog owners to realise that they don’t have to wait until they are in crisis to call us for help.”